Dawn Slown

About Dawn Slown

Dawn Slown is a research director in Market Strategies’ Life Sciences Research division. She is the day-to-day contact for all phases of research and is responsible for managing the project team. Dawn brings 15 years of experience in brand and communications research expertise to the company, with experience across many industries, but her focus has always been on pharma (consumer and Rx). She has contributed to award-winning creative campaigns, led countless communication testing programs and developed brand health tracking work to drive brand growth. Dawn earned a bachelor’s degree in advertising from Murray State University. In her free time, she enjoys traveling with her family, cooking from scratch and is an avid hockey, lacrosse, tennis, and equestrian fan (i.e., sports her children play).

My Mom, a Caregiver: Portrait of an Overlooked Hero

How the Healthcare Industry Is Failing 29% of the US Population  
My Mom-a Caregiver-Portrait of a Hidden Hero

If you’re like me, you have firsthand experience watching someone you love care for the health of another person. I watched my mother care for her husband of 50 years, who battled cancer, cardiovascular disease and diabetes. Every day for nearly 12 years she made sure he was eating right, taking his medications, attending health-related appointments, and purchasing the healthcare products he needed for the day-to-day management of his conditions.

Like many caregivers, my mother was also caring for another family member at the same time. Her father needed help as he dealt with a variety of ailments as he slid into his 90s, and she had to make sure he was getting proper nutrition, accessing wound care, keeping his body active and mobile, and addressing his vision issues. Additionally, while she cared for the two men who meant the world to her, she managed to work part-time and maintain relationships with the rest of her family and friends. She is the matriarch of our family and appeared to handle the stress effortlessly. However, I recently discovered after a heart-felt conversation with her that it was not as effortless as she made it appear. Continue reading

Are PAPs the Panacea for What Ails Pharma Companies?

Are PAPs the Panacea for What Ails Pharma Companies?

Sixty percent of Americans suffer from a chronic disease, making the need for affordable treatment options critical. Even with health insurance, sufferers struggle to manage their condition as prescription costs continue to rise and shift to the patient. The repercussions of this trend cascade through the patient-provider relationship, which now includes insurance and pharmaceutical companies.

Market Strategies International recently conducted a study of more than 1,000 adults age 18 and older to understand the impact of rising prescription costs in three key areas:

  1. Intentional prescription non-compliance
  2. Consumer attitudes towards healthcare providers, health insurance providers and pharmaceutical companies
  3. Consumer awareness and enrollment in patient assistance programs (PAPs)

What we found is a huge gap between needs and value as well as a strong indication that PAPs may be the panacea for improving compliance and attitudes towards pharmaceutical companies.

Continue reading